Your friend that only smokes pure indica because sativa 'makes them paranoid?' Scientists have confirmed your sneaking suspicion that these dopers are just blowing smoke.

As any serious toker will point out, cannabis is among the planet's oldest cultivated crops. But driven underground, marijuana growth has been a genetic free-for-all, with cross-breeding mixing up even the most basic distinction — between indica and sativa — that many hold dear. 

10. Treatment of Glaucoma

If you are one of the millions who have been suffering from glaucoma, then smoking marijuana can help you get the best eyesight and relieve pressure from they eyes. Intraocular pressure can increase in certain individuals, especially those who have diabetes. Glaucoma is serious disease that can cause blindness.

9. Manage Epileptic Seizures

People who suffer from epileptic disorders or seizures can get tremendous relief and relaxation from smoking marijuana.

8. Pain Reliever

“O Lord my God, I cried unto Thee, and Thou didst heal me.” (Psalms 30:3)

Israeli researchers have long been on the cutting edge of medical marijuana research. Now a team of scientists from Tel Aviv University have shown that certain compounds found in cannabis can help treat multiple sclerosis-like diseases by preventing inflammation in the brain and spinal cord.

Cannabidiol (CBD), a compound found exclusively in the cannabis plant, may treat acne, according to a study published in theJournal of Clinical Investigation, and published online by the National Institute of Health.

For the study, researchers used cannabidiol derived from cannabis on human sebaceous gland function (glands that secrete an oily or waxy matter to lubricate the skin and hair), and determined that CBD is effective in deterring the acne that this secretion can cause.

The latest research adds to the debate over marijuana's effects on the brain

Using marijuana does not cause changes in brain volume, a new study suggests.

Public health experts have cited concerns that using marijuana could be associated with structural changes in the brain. However, a new trial comparing the brains of marijuana users and non-users to their siblings reveals that marijuana use likely does not cause changes in brain volume.

The state of Georgia has been scrambling to figure out a way to lay the groundwork of a newly legalized industry overnight. 

One California grower told a state commission on Wednesday that 25 acres — or one million square feet — would be enough space to produce all of the medical marijuana needed to treat Georgia patients.

The Commission on Medical Cannabis faces the demanding task of deciding how to lay down the infrastructure for the state’s medical marijuana industry. The most contentious issue to date is how to structure and regulate the oil’s cultivation and production.

Aubrie Hill, 20, grew up in Huntsville but moved to California earlier this month to have legal access to medical marijuana to help treat her epilepsy.

The passion and the energy resonated from California to Alabama, the video interview providing a window into the raw determination that drives Vicki Hill.

She left 32 years of her life behind in Huntsville to relocate to northern California in search of a medical marijuana sanctuary for her 20-year-old daughter, Aubrie, who has suffered from epilepsy since she was 5.

The latest research adds to the debate over marijuana's effects on the brain

Using marijuana does not cause changes in brain volume, a new study suggests.

Public health experts have cited concerns that using marijuana could be associated with structural changes in the brain. However, a new trial comparing the brains of marijuana users and non-users to their siblings reveals that marijuana use likely does not cause changes in brain volume.

The Brazilian pharmaceutical market will expand in value from $29.4 billion in 2014 to reach approximately $47.9 billion by 2020, representing a strong Compound Annual Growth Rate (CAGR) of 8.5 percent, according to research and consulting firm GlobalData.

The company’s latest report states that Brazil’s increasingly elderly population, which will lead to a rising incidence of chronic and lifestyle-associated diseases, as well as the country’s robust investment in healthcare, will be key drivers of market growth during the forecast period.

The Brazilian pharmaceutical industry continues to prosper, primarily thanks to the country’s economic policies and reforms.

A team of researchers at Phylos Bioscience launched the Cannabis Evolution Project last year in an effort to map the genetic structure of marijuana, effectively protecting the biodiversity of cannabis from corporate interests, such as Monsanto, which might be tempted to capitalize on legal weed by securing exclusive patents on select strains.